<?xml version="1.0" encoding="utf-8" ?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/" xmlns="http://purl.org/rss/1.0/">




    



<channel rdf:about="http://www.australianprostatecentre.org/research/clinical-trials/RSS">
  <title>Clinical Trials</title>
  <link>http://www.australianprostatecentre.org</link>

  <description>
    
      
    
  </description>

  

  
            <syn:updatePeriod>daily</syn:updatePeriod>
            <syn:updateFrequency>1</syn:updateFrequency>
            <syn:updateBase>2014-02-11T05:00:15Z</syn:updateBase>
        

  <image rdf:resource="http://www.australianprostatecentre.org/logo.png"/>

  <items>
    <rdf:Seq>
      
        <rdf:li rdf:resource="http://www.australianprostatecentre.org/grants/upfront-psma-alliance"/>
      
      
        <rdf:li rdf:resource="http://www.australianprostatecentre.org/research/preventing-the-respiratory-failure-causing-covid-19-mortality-potent-new-drugs-targeting-hyperinflammation"/>
      
      
        <rdf:li rdf:resource="http://www.australianprostatecentre.org/grants/australian-canadian-prostate-cancer-research-alliance"/>
      
      
        <rdf:li rdf:resource="http://www.australianprostatecentre.org/grants/circulating-tumour-cells-collaborative-prostate-cancer-biomarker-project"/>
      
      
        <rdf:li rdf:resource="http://www.australianprostatecentre.org/grants/establishment-of-the-australian-prostate-cancer-research-centre-queensland"/>
      
      
        <rdf:li rdf:resource="http://www.australianprostatecentre.org/grants/evaluation-of-prostate-specific-membrane-antigen-based-pet-and-mri-for-the-detection-of-multiple-cancer-foci-in-localised-prostate-cancer-patients"/>
      
      
        <rdf:li rdf:resource="http://www.australianprostatecentre.org/grants/movember-australian-survivorship-action-partnership"/>
      
      
        <rdf:li rdf:resource="http://www.australianprostatecentre.org/grants/pilot-study-to-evaluate-the-prognostic-and-metabolic-benefits-of-metformin-during-androgen-deprivation-therapy-in-metastatic-prostate-cancer"/>
      
      
        <rdf:li rdf:resource="http://www.australianprostatecentre.org/grants/movember-revolutionary-team-award-adaptive-response-to-targeting-the-androgen-axis-a-strategic-offensive-on-resistance"/>
      
      
        <rdf:li rdf:resource="http://www.australianprostatecentre.org/grants/precision-medicine-in-advanced-and-oligometastatic-prostate-cancer"/>
      
      
        <rdf:li rdf:resource="http://www.australianprostatecentre.org/grants/precision-medicine-in-advanced-prostate-cancer"/>
      
      
        <rdf:li rdf:resource="http://www.australianprostatecentre.org/grants/global-action-plan-4"/>
      
      
        <rdf:li rdf:resource="http://www.australianprostatecentre.org/grants/feasibility-study-identification-of-prostate-cancer-recurrence-sites-by-gallium-labelled-psma-pet-mri-in-patients-with-biochemical-recurrence-following-definitive-therapy"/>
      
      
        <rdf:li rdf:resource="http://www.australianprostatecentre.org/grants/a-novel-liver-targeted-therapy-for-sarcopaenia-in-androgen-deprived-men-with-prostate-cancer"/>
      
      
        <rdf:li rdf:resource="http://www.australianprostatecentre.org/grants/pilot-study-of-diagnostic-accuracy-of-psma-pet-mri-mp-mri-mri-uss-fusion-biopsy-and-prolaris-genomic-risk-stratifier"/>
      
    </rdf:Seq>
  </items>

</channel>


  <item rdf:about="http://www.australianprostatecentre.org/grants/upfront-psma-alliance">
    <title>Upfront PSMA Alliance</title>
    <link>http://www.australianprostatecentre.org/grants/upfront-psma-alliance</link>
    <description></description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>Kathryn Arthy</dc:creator>
    <dc:rights></dc:rights>
    <dc:date>2020-03-10T00:43:48Z</dc:date>
    <dc:type>Grant</dc:type>
  </item>


  <item rdf:about="http://www.australianprostatecentre.org/research/preventing-the-respiratory-failure-causing-covid-19-mortality-potent-new-drugs-targeting-hyperinflammation">
    <title>Preventing the Respiratory Failure Causing COVID-19 Mortality, Potent New Drugs Targeting Hyperinflammation</title>
    <link>http://www.australianprostatecentre.org/research/preventing-the-respiratory-failure-causing-covid-19-mortality-potent-new-drugs-targeting-hyperinflammation</link>
    <description></description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>Lisa Philp</dc:creator>
    <dc:rights></dc:rights>
    <dc:date>2021-08-12T04:58:19Z</dc:date>
    <dc:type>Grant</dc:type>
  </item>


  <item rdf:about="http://www.australianprostatecentre.org/grants/australian-canadian-prostate-cancer-research-alliance">
    <title>Australian-Canadian Prostate Cancer Research Alliance </title>
    <link>http://www.australianprostatecentre.org/grants/australian-canadian-prostate-cancer-research-alliance</link>
    <description>This Alliance is a critical network of academic and clinical experts connected with leading edge technologies who can apply their coordinated energies to solve the complex problems facing prostate cancer. </description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator> Kim Rasmussen</dc:creator>
    <dc:rights></dc:rights>
    <dc:date>2014-03-06T04:47:33Z</dc:date>
    <dc:type>Grant</dc:type>
  </item>


  <item rdf:about="http://www.australianprostatecentre.org/grants/circulating-tumour-cells-collaborative-prostate-cancer-biomarker-project">
    <title>Circulating Tumour Cells Collaborative Prostate Cancer Biomarker Project</title>
    <link>http://www.australianprostatecentre.org/grants/circulating-tumour-cells-collaborative-prostate-cancer-biomarker-project</link>
    <description>In order to improve capture and molecular and cellular analyses of Circulating Tumour Cells and CTMs in prostate cancer patients, we will compare and refine methodologies via a collaborative approach. As a collective team, we have complementary prostate cancer patients on defined clinical trials or protocols which we will use to assess identified individual biomarkers and/or biological classes or signatures to provide biological information with potential clinical significance to prostate cancer progression and metastasis.
</description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>Kathryn Arthy</dc:creator>
    <dc:rights></dc:rights>
    <dc:date>2014-03-06T05:40:00Z</dc:date>
    <dc:type>Grant</dc:type>
  </item>


  <item rdf:about="http://www.australianprostatecentre.org/grants/establishment-of-the-australian-prostate-cancer-research-centre-queensland">
    <title>Establishment of the Australian Prostate Cancer Research Centre – Queensland </title>
    <link>http://www.australianprostatecentre.org/grants/establishment-of-the-australian-prostate-cancer-research-centre-queensland</link>
    <description>The DOHA funding established APCRC-Q as an integrated, transdisciplinary, comprehensive prostate cancer research centre.</description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator> Kim Rasmussen</dc:creator>
    <dc:rights></dc:rights>
    <dc:date>2014-03-06T05:35:00Z</dc:date>
    <dc:type>Grant</dc:type>
  </item>


  <item rdf:about="http://www.australianprostatecentre.org/grants/evaluation-of-prostate-specific-membrane-antigen-based-pet-and-mri-for-the-detection-of-multiple-cancer-foci-in-localised-prostate-cancer-patients">
    <title>Evaluation of Prostate-specific Membrane Antigen Based PET and MRI for the Detection of Multiple Cancer Foci in Localised Prostate Cancer Patients</title>
    <link>http://www.australianprostatecentre.org/grants/evaluation-of-prostate-specific-membrane-antigen-based-pet-and-mri-for-the-detection-of-multiple-cancer-foci-in-localised-prostate-cancer-patients</link>
    <description>In this study, 68Ga-PSMA PET and MP MRI will be compared with whole-mount pathology to evaluate the applicability of 68Ga-PSMA PET and MP MRI for detecting and locating tumour foci as well as to characterise 68Ga-PSMA uptake in patients with localised prostate cancer. All the imaging results will be compared with whole-mount prostate gland histology. </description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>Kathryn Arthy</dc:creator>
    <dc:rights></dc:rights>
    <dc:date>2014-03-06T05:40:00Z</dc:date>
    <dc:type>Grant</dc:type>
  </item>


  <item rdf:about="http://www.australianprostatecentre.org/grants/movember-australian-survivorship-action-partnership">
    <title>TrueNTH - an integrated multi-component intervention to improve the lives of men with prostate cancer in Australia</title>
    <link>http://www.australianprostatecentre.org/grants/movember-australian-survivorship-action-partnership</link>
    <description>The Movember Foundation has established the TrueNTH program to develop and implement an integrated multi-component care model to tackle critical areas of prostate cancer care. </description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator> Kim Rasmussen</dc:creator>
    <dc:rights></dc:rights>
    <dc:date>2014-03-06T05:40:00Z</dc:date>
    <dc:type>Grant</dc:type>
  </item>


  <item rdf:about="http://www.australianprostatecentre.org/grants/pilot-study-to-evaluate-the-prognostic-and-metabolic-benefits-of-metformin-during-androgen-deprivation-therapy-in-metastatic-prostate-cancer">
    <title>ADMET Random control trial to evaluate the prognostic and metabolic benefits of metformin during androgen deprivation therapy in metastatic prostate cancer</title>
    <link>http://www.australianprostatecentre.org/grants/pilot-study-to-evaluate-the-prognostic-and-metabolic-benefits-of-metformin-during-androgen-deprivation-therapy-in-metastatic-prostate-cancer</link>
    <description>The aim of this project is to evaluate the effect of metformin in a longitudinal study of advanced metastatic prostate cancer patients undergoing ADT, monitoring metabolic response and candidate androgen, epithelial to mesenchymal transition (EMT), and metabolic signatures within CTCs. </description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator> Kim Rasmussen</dc:creator>
    <dc:rights></dc:rights>
    <dc:date>2014-03-06T05:40:00Z</dc:date>
    <dc:type>Grant</dc:type>
  </item>


  <item rdf:about="http://www.australianprostatecentre.org/grants/movember-revolutionary-team-award-adaptive-response-to-targeting-the-androgen-axis-a-strategic-offensive-on-resistance">
    <title>Revolutionary Team Award - Adaptive Response to Targeting the Androgen Axis: A Strategic Offensive on Resistance</title>
    <link>http://www.australianprostatecentre.org/grants/movember-revolutionary-team-award-adaptive-response-to-targeting-the-androgen-axis-a-strategic-offensive-on-resistance</link>
    <description>Our ultimate goal is to capitalise on adaptive pathways activated by inhibition of the androgen axis to identify and strategically develop drugs to be used in combination or in sequence with androgen targeted therapies to improve outcomes in advanced prostate cancer.</description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>Kathryn Arthy</dc:creator>
    <dc:rights></dc:rights>
    <dc:date>2014-03-17T01:55:00Z</dc:date>
    <dc:type>Grant</dc:type>
  </item>


  <item rdf:about="http://www.australianprostatecentre.org/grants/precision-medicine-in-advanced-and-oligometastatic-prostate-cancer">
    <title>Precision medicine in advanced and oligometastatic prostate cancer </title>
    <link>http://www.australianprostatecentre.org/grants/precision-medicine-in-advanced-and-oligometastatic-prostate-cancer</link>
    <description></description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>Kathryn Arthy</dc:creator>
    <dc:rights></dc:rights>
    <dc:date>2016-03-17T01:40:00Z</dc:date>
    <dc:type>Grant</dc:type>
  </item>


  <item rdf:about="http://www.australianprostatecentre.org/grants/precision-medicine-in-advanced-prostate-cancer">
    <title>Precision medicine in advanced prostate cancer</title>
    <link>http://www.australianprostatecentre.org/grants/precision-medicine-in-advanced-prostate-cancer</link>
    <description></description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>Kathryn Arthy</dc:creator>
    <dc:rights></dc:rights>
    <dc:date>2016-03-17T02:25:00Z</dc:date>
    <dc:type>Grant</dc:type>
  </item>


  <item rdf:about="http://www.australianprostatecentre.org/grants/global-action-plan-4">
    <title>Global Action Plan 4 - INTense Exercise foR surVivAL among men with Metastatic Prostate Cancer (INTERVAL – GAP4)</title>
    <link>http://www.australianprostatecentre.org/grants/global-action-plan-4</link>
    <description></description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>Kathryn Arthy</dc:creator>
    <dc:rights></dc:rights>
    <dc:date>2016-03-17T05:45:00Z</dc:date>
    <dc:type>Grant</dc:type>
  </item>


  <item rdf:about="http://www.australianprostatecentre.org/grants/feasibility-study-identification-of-prostate-cancer-recurrence-sites-by-gallium-labelled-psma-pet-mri-in-patients-with-biochemical-recurrence-following-definitive-therapy">
    <title>Feasibility Study - Identification of prostate cancer recurrence sites by Gallium-labelled PSMA PET/MRI in patients with biochemical recurrence following definitive therapy</title>
    <link>http://www.australianprostatecentre.org/grants/feasibility-study-identification-of-prostate-cancer-recurrence-sites-by-gallium-labelled-psma-pet-mri-in-patients-with-biochemical-recurrence-following-definitive-therapy</link>
    <description></description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>Kathryn Arthy</dc:creator>
    <dc:rights></dc:rights>
    <dc:date>2017-02-09T06:40:00Z</dc:date>
    <dc:type>Grant</dc:type>
  </item>


  <item rdf:about="http://www.australianprostatecentre.org/grants/a-novel-liver-targeted-therapy-for-sarcopaenia-in-androgen-deprived-men-with-prostate-cancer">
    <title>A novel liver targeted therapy for sarcopaenia in androgen deprived men with prostate cancer</title>
    <link>http://www.australianprostatecentre.org/grants/a-novel-liver-targeted-therapy-for-sarcopaenia-in-androgen-deprived-men-with-prostate-cancer</link>
    <description></description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>Kathryn Arthy</dc:creator>
    <dc:rights></dc:rights>
    <dc:date>2017-02-09T06:45:00Z</dc:date>
    <dc:type>Grant</dc:type>
  </item>


  <item rdf:about="http://www.australianprostatecentre.org/grants/pilot-study-of-diagnostic-accuracy-of-psma-pet-mri-mp-mri-mri-uss-fusion-biopsy-and-prolaris-genomic-risk-stratifier">
    <title>Pilot study of diagnostic accuracy of PSMA PET/MRI, mp MRI, MRI USS fusion biopsy and 'prolaris' genomic risk stratifier</title>
    <link>http://www.australianprostatecentre.org/grants/pilot-study-of-diagnostic-accuracy-of-psma-pet-mri-mp-mri-mri-uss-fusion-biopsy-and-prolaris-genomic-risk-stratifier</link>
    <description></description>
    
    <dc:publisher>No publisher</dc:publisher>
    <dc:creator>Kathryn Arthy</dc:creator>
    <dc:rights></dc:rights>
    <dc:date>2018-01-24T23:45:00Z</dc:date>
    <dc:type>Grant</dc:type>
  </item>





</rdf:RDF>
